Monash University – World #2 launches new Master of Pharmaceutical Science
Date Posted – 25 May 2021 Monash University has launched a new postgraduate degree to address a major skills shortage in the Australian pharmaceutical sector and its allied industries. The Master of Pharmaceutical Science will be offered by…
Rhinomed Rhinoswab Secures European CE Mark
Date Posted – 20 May 2021 Rhinomed Limited (ASX:RNO OTCQB:RHNMF), a leader in wearable nasal and respiratory technology, is pleased to announce it has been advised by Medical Device Safety Service GmbH (MDSS) that an Authorized Representative’s Mandate…
New antimicrobial surface reduces bacteria build-up on medical instruments – Monash University
Date Posted – 20 May 2021 Patient infection from urinary catheters are a global health concern. In a world-first, Monash University researchers have developed a new 3D antimicrobial surface to reduce bacterial build-up. The study saw a reduction…
Silicosis research awarded more than $1.6 million – Hudson Institute of Medical Research and Monash University
Date Posted – 20 May 2021 A deadly and incurable lung disease afflicting Australian tradies could be prevented from progressing and successfully treated, following a multi-million federal funding boost to silicosis research. Hudson Institute of Medical Research and…
Victorian budget invests in the health of Generation Victoria – MCRI
Date Posted – 20 May 2021 The Murdoch Children’s Research Institute (MCRI) welcomes the additional investment from the Victorian Government of $14 million AUD to support its innovative Generation Victoria (GenV) research project. The first project of its kind in Australia, GenV…
Accelagen – A 10 Year Overnight Success Story
Date Posted – 20 May 2021 Accelagen, a Melbourne based Regulatory Affairs, Clinical Research and Development Organisation, has come from humble beginnings and grown into a highly successful, effective and committed Contract Research Organisation (CRO) working with…
Snoretox wins MRFF Frontier Grant
Date Posted – 17 May 2021 The Minister for Health has announced that Snoretox has won a Medical Research Future Fund (MRFF) 2021 Frontier Health and Medical Research Initiative Grant, securing a 1 Million dollar 12 month grant and…
Imagion Biosystems and Patrys to Collaborate on Brain Tumor Imaging
Date Posted – 3 May 2021 Imagion Biosystems Limited (ASX: IBX), a company dedicated to improving healthcare through the earlier detection of cancer, and Patrys Limited (ASX: PAB), a therapeutic antibody development company, are pleased to announce a…
Mutiple Dose Part Of Ad-214 Phase I Trial Commenced – AdAlta
Date Posted – 19 April 2021 AdAlta Limited (ASX:1AD), the clinical stage biotechnology company developing novel medicines using its i-body platform is pleased to announce that the first cohort of healthy volunteers have received the first of three…
First Patients Benefit from Victoria’s Non-Invasive Gamma Knife
Date Posted – 8 April 2021 The first Gamma Knife to be installed in Victoria, at Peter MacCallum Cancer Centre, is now fully operational, with the first patients to receive the non-invasive radiosurgery sharing their experiences. The Gamma…
Mr Peter Giannopoulos appointed as CEO of Cell Therapies Pty Ltd
Date Posted – 6 April 2021 Cell Therapies Pty Ltd, a leading provider of cell and gene therapy products in the Asia Pacific region, is delighted to announce the appointment of Mr Peter Giannopoulos as the company’s new Chief Executive…
University of Sydney receives approval to start COVALIA, a Phase 1 Clinical trial of COVIGEN, a New COVID-19 Vaccine Candidate in Australia
Date Posted – 26 March 2021 Date Published – 22 March 2021 First needle-free DNA-based COVID-19 candidate vaccine to be tested in Australia in a phase 1 trial in healthy subjects aged 18 to 75 years old •…
